Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPMC Blueprint Medicines Corporation

交易中 07-17 09:45:16 EDT

117.54

-2.96

-2.46%

最高117.84	最低114.44	成交量3.17万
今开115.92	昨收120.50	日振幅2.82%
总市值73.60亿	流通市值72.77亿	总股本6,262万
成交额368.77万	换手率0.05%	流通股本6,191万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPMC","market":"US","secType":"STK","nameCN":"Blueprint Medicines Corporation","latestPrice":117.535,"timestamp":1721223914664,"preClose":120.5,"halted":0,"volume":31679,"delay":0,"floatShares":61910871,"shares":62616902,"eps":-4.732122,"marketStatus":"交易中","marketStatusCode":2,"change":-2.965,"latestTime":"07-17 09:45:16 EDT","open":115.92,"high":117.84,"low":114.44,"amount":3687691.122814,"amplitude":0.028216,"askPrice":117.73,"askSize":81,"bidPrice":117.34,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.732122,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721246400000},"adr":0,"listingDate":1430366400000,"adjPreClose":120.5,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":116.72,"preClose":120.5,"latestTime":"09:29 EDT","volume":569,"amount":65735.87923399999,"timestamp":1721222999999},"postHourTrading":{"tag":"盘后","latestPrice":120.5,"preClose":120.5,"latestTime":"16:17 EDT","volume":61656,"amount":7429546.01,"timestamp":1721161039764},"volumeRatio":1.413586,"impliedVol":0.4979,"impliedVolPercentile":0.119},"requestUrl":"/m/hq/s/BPMC/tweets","defaultTab":"tweets","newsList":[{"id":"2449709567","title":"Blueprint Medicines Corporation盘中异动 股价大涨5.13%报117.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449709567","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449709567?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:25","pubTimestamp":1720448700,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时25分，Blueprint Medicines Corporation股票出现波动，股价快速拉升5.13%。截至发稿，该股报117.43美元/股，成交量23.4079万股，换手率0.37%，振幅3.73%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.85%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222500aef87a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222500aef87a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2439857430","title":"Blueprint Medicines Corporation跌2.31% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2439857430","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439857430?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:09","pubTimestamp":1716995378,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时09分，Blueprint Medicines Corporation股票出现异动，股价急速跳水2.31%。截至发稿，该股报100.00美元/股，成交量4.2175万股，换手率0.07%，振幅1.49%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Mustang Bio, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为406.99%、97.68%、29.41%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Mustang Bio, Inc.、冠科美博，振幅分别为97.00%、50.08%、44.82%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529230938af8af0a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529230938af8af0a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","BK4139","BK4505"],"gpt_icon":0},{"id":"2437039384","title":"Blueprint Medicines——在Ayvakit的销售额超过里程碑之后贷款机构于5月22日资助了B批延期提取1.50亿美元的定期贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2437039384","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437039384?lang=zh_cn&edition=full","pubTime":"2024-05-24 20:16","pubTimestamp":1716552973,"startTime":"0","endTime":"0","summary":"Blueprint Medicines——在Ayvakit的销售额超过里程碑之后贷款机构于5月22日资助了B批延期提取1.50亿美元的定期贷款","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242016169ee2c5d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242016169ee2c5d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2434869435","title":"Blueprint Medicines Corporation2024财年第一财季实现净利润89.14百万美元，同比增加168.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869435","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434869435?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:19","pubTimestamp":1715357976,"startTime":"0","endTime":"0","summary":"3月31日，Blueprint Medicines Corporation公布财报，公告显示公司2024财年第一财季净利润为89.14百万美元，同比增加168.57%；其中营业收入为96.12百万美元，同比增加51.87%，每股基本收益为1.45美元。从资产负债表来看，Blueprint Medicines Corporation总负债7.28亿美元，其中短期债务87.15百万美元，资产负债比为1.43，流动比率为3.76。机构评级：截至2024年3月31日，当前有16家机构对Blueprint Medicines Corporation目标价做出预测，其中目标均价为118.12美元，其中最低目标价为75.00美元，最高目标价为168.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019498af1a835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019498af1a835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC"],"gpt_icon":0},{"id":"2432134921","title":"HC Wainwright & Co.：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由125.00美元调整至135.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432134921","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432134921?lang=zh_cn&edition=full","pubTime":"2024-05-04 04:25","pubTimestamp":1714767928,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由125.00美元调整至135.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040425338b714e7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040425338b714e7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC"],"gpt_icon":0},{"id":"2432323949","title":"Blueprint Medicines 公司报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432323949","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432323949?lang=zh_cn&edition=full","pubTime":"2024-05-03 02:55","pubTimestamp":1714676152,"startTime":"0","endTime":"0","summary":"   * Blueprint Medicines Corp   报告了截至3月底的季度调整后每股收益1.40美元，高于去年同期的每股收益2.15美元。华尔街预期为每股亏损 1.80 美元至 1.46 美元。* Blueprint Medicines Corp公布的本季度每股收益为1.40美元。* 公司报告的季度净收入为 8914 万美元。* Blueprint Medicines Corp 的股价本季度迄今保持稳定，今年迄今上涨了 2.8%。5月2日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 3.7%。华尔街对 Blueprint Medicines Corp 的 12 个月目标价中位数为 113.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BPMC","BK4139"],"gpt_icon":0},{"id":"2432601696","title":"Blueprint Medicines Corporation盘中异动 股价大涨8.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432601696","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432601696?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:32","pubTimestamp":1714656759,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时32分，Blueprint Medicines Corporation股票出现波动，股价急速上涨8.43%。截至发稿，该股报102.86美元/股，成交量7.9334万股，换手率0.13%，振幅4.32%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为1515.37%、302.91%、83.03%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为30.66%、22.07%、18.71%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221323987cb11be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221323987cb11be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2432635229","title":"Blueprint Medicines Corporation盘中异动 股价大涨5.23%报96.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635229","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432635229?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:00","pubTimestamp":1714590014,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时00分，Blueprint Medicines Corporation股票出现波动，股价快速上涨5.23%。截至发稿，该股报96.12美元/股，成交量39.1326万股，换手率0.62%，振幅5.53%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为2.35%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1414.05%、1217.31%、267.12%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502030014861ea95b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502030014861ea95b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2432830617","title":"Blueprint Medicines Corp   预计每股亏损1.66美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432830617","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432830617?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:25","pubTimestamp":1714497927,"startTime":"0","endTime":"0","summary":"   * Blueprint Medicines Corp    将于5月2日公布截至2024年3月31日的财报，预计季度收入将有所增长。* 根据LSEG的数据，15位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收将从去年同期的6329万美元增至8043.4万美元，增幅为27.1%。* LSEG分析师对Blueprint Medicines Corp的平均预期是每股亏损1.66美元。* 华尔街对 Blueprint Medicines Corp 的 12 个月目标价中位数为 100.00 美元，高于其 93.10 美元的最新收盘价。4月30日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPMC"],"gpt_icon":0},{"id":"2429970603","title":"Blueprint Medicines Corporation盘中异动 快速上涨5.01%报91.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429970603","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429970603?lang=zh_cn&edition=full","pubTime":"2024-04-23 02:21","pubTimestamp":1713810108,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日02时21分，Blueprint Medicines Corporation股票出现异动，股价大幅上涨5.01%。截至发稿，该股报91.20美元/股，成交量27.9366万股，换手率0.46%，振幅5.23%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为2.08%。其相关个股中，Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa涨幅较大，Moolec Science Sa、Phio Pharmaceuticals Corp.、Nkgen Biotech, Inc.较为活跃，换手率分别为198.91%、118.65%、89.33%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Phio Pharmaceuticals Corp.，振幅分别为252.97%、82.14%、68.75%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042302214887e8291e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042302214887e8291e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2426491777","title":"Blueprint Medicines Corporation盘中异动 股价大跌8.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426491777","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426491777?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755847,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Blueprint Medicines Corporation股票出现异动，股价急速跳水8.26%。截至发稿，该股报84.58美元/股，成交量2.3663万股，换手率0.04%，振幅2.23%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Vbi Vaccines, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为753.89%、61.90%、20.41%，振幅较大的相关个股有Foghorn Therapeutics Inc.、Adial Pharmaceuticals, Inc、Century Therapeutics, Inc.，振幅分别为9.52%、7.96%、7.73%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213047791faba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213047791faba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","BK4505","BK4139"],"gpt_icon":0},{"id":"2424002046","title":"Blueprint Medicines Corporation盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424002046","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424002046?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:06","pubTimestamp":1712066793,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时06分，Blueprint Medicines Corporation股票出现波动，股价快速下挫5.01%。截至发稿，该股报91.59美元/股，成交量8.1658万股，换手率0.13%，振幅3.08%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为1.76%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022206337a50b742&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022206337a50b742&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2422894624","title":"Blueprint Medicines Corporation盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422894624","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422894624?lang=zh_cn&edition=full","pubTime":"2024-03-28 01:10","pubTimestamp":1711559443,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日01时10分，Blueprint Medicines Corporation股票出现异动，股价快速拉升5.06%。截至发稿，该股报94.21美元/股，成交量20.658万股，换手率0.34%，振幅5.15%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3513.55%、1232.79%、79.14%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.，振幅分别为99.13%、78.00%、59.87%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280110437a4f8e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280110437a4f8e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","BK4139","BK4505"],"gpt_icon":0},{"id":"2414223380","title":"Blueprint Medicines Corp盘中异动 股价大涨5.07%报99.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414223380","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414223380?lang=zh_cn&edition=full","pubTime":"2024-02-28 04:53","pubTimestamp":1709067208,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日04时53分，Blueprint Medicines Corp股票出现异动，股价大幅上涨5.07%。截至发稿，该股报99.87美元/股，成交量114.028万股，换手率1.86%，振幅5.03%。Blueprint Medicines Corp股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Jaguar Health Inc较为活跃，换手率分别为374.09%、243.23%、95.76%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Janux Therapeutics Inc、Viking Therapeutics Inc，振幅分别为169.78%、117.55%、84.30%。Blueprint Medicines Corp公司简介：Blueprint Medicines Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022804532987e73abb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022804532987e73abb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2414066836","title":"Blueprint Medicines Corp盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414066836","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414066836?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:30","pubTimestamp":1708961410,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时30分，Blueprint Medicines Corp股票出现波动，股价急速拉升5.02%。截至发稿，该股报93.98美元/股，成交量16.6059万股，换手率0.27%，振幅5.10%。Blueprint Medicines Corp股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Zyversa Therapeutics Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Krystal Biotech Inc涨幅较大，Zyversa Therapeutics Inc、Ocean Biomedical Inc、Lixte Biotechnology Holdings  Inc较为活跃，换手率分别为1364.92%、76.41%、61.96%，振幅较大的相关个股有Zyversa Therapeutics Inc、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ocean Biomedical Inc，振幅分别为144.82%、62.88%、61.14%。Blueprint Medicines Corp公司简介：Blueprint Medicines Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240226233010861d86bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240226233010861d86bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BPMC","BK4505","BK4139"],"gpt_icon":0},{"id":"2413824762","title":"Blueprint Medicines Corp盘中异动 大幅拉升5.38%报90.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413824762","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413824762?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:54","pubTimestamp":1708700053,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时54分，Blueprint Medicines Corp股票出现波动，股价急速上涨5.38%。截至发稿，该股报90.63美元/股，成交量7.9449万股，换手率0.13%，振幅4.32%。Blueprint Medicines Corp股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Ocean Biomedical Inc、Maravai Lifesciences Hldgs Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Enveric Biosciences Inc、Biodexa Pharmaceuticals Plc、Monopar Therapeutics Inc较为活跃，换手率分别为295.63%、125.18%、106.20%，振幅较大的相关个股有Ocean Biomedical Inc、Monopar Therapeutics Inc、Cara Therapeutics Inc，振幅分别为52.58%、32.14%、28.79%。Blueprint Medicines Corp公司简介：Blueprint Medicines Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240223225413861d7ed6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240223225413861d7ed6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2413921716","title":"BUZZ-Rigel 制药公司获得肺癌药物美国销售权后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2413921716","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413921716?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:29","pubTimestamp":1708615754,"startTime":"0","endTime":"0","summary":"    2月22日 - ** 制药商Rigel Pharmaceuticals   股价上涨4.9%，至1.17美元 ** 公司将从 Blueprint Medicines    公司获得  肺癌药物 Gavreto 在美国的销售权。根据协议，RIGL 将向 Blueprint 支付 1,500 万美元，其中 1,000 万美元在该药物首次商业销售时支付，另外 500 万美元在交易完成日期一周年时支付。** 过去12个月里，Rigel公司股价下跌了27.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RIGL","BPMC","BK4505","BUZZ"],"gpt_icon":0},{"id":"2413405580","title":"Blueprint Medicines Corp盘中异动 下午盘急速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413405580","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413405580?lang=zh_cn&edition=full","pubTime":"2024-02-22 04:11","pubTimestamp":1708546291,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日04时11分，Blueprint Medicines Corp股票出现异动，股价急速下跌5.04%。截至发稿，该股报86.65美元/股，成交量53.1934万股，换手率0.87%，振幅6.33%。Blueprint Medicines Corp股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Ventyx Biosciences Inc涨幅较大，Revelation Biosciences Inc、Ventyx Biosciences Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为297.19%、142.47%、78.62%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ventyx Biosciences Inc，振幅分别为162.34%、129.75%、117.73%。Blueprint Medicines Corp公司简介：Blueprint Medicines Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022204113287e71f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022204113287e71f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2411066519","title":"Blueprint Medicines Corp盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411066519","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411066519?lang=zh_cn&edition=full","pubTime":"2024-02-16 22:34","pubTimestamp":1708094074,"startTime":"0","endTime":"0","summary":"北京时间2024年02月16日22时34分，Blueprint Medicines Corp股票出现异动，股价急速上涨5.32%。Blueprint Medicines Corp股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Ys Biopharma Co Ltd C/Wts 15/03/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Revolution Medicines Inc C/Wts  涨幅较大，Kintara Therapeutics Inc、Tc Biopharm  Plc、Novabay Pharmaceuticals Inc较为活跃，换手率分别为10.50%、9.05%、6.63%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Sangamo Therapeutics Inc，振幅分别为41.99%、28.41%、14.29%。Blueprint Medicines Corp公司简介：Blueprint Medicines Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021622343587e705e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021622343587e705e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Bloom Energy Corp   ：KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元  * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","CALC","ANGI","LU0109391861.USD","TXG","LU1815336760.USD","BJRI","BXMT","CBT","BK4090","CF","LU2065171311.SGD","AWK","CVNA","AORT","CBRE","CDRE","LU0820562030.AUD","BHF","BLZE","BPMC","APLE","BK4548","AEL","NVDA","ANGO","ANIP","APD","AMAT","BE","BIO","LU0208291251.USD","HOUS","LU0316494557.USD","AGIO","BWA","IE00BJJMRX11.SGD","ALNY","CACI","FUN","ARCH","AIG","ALB","ATRC","CMBM","LU2249611893.SGD","IE00BFSS8Q28.SGD","AR","BHVN","CWST"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blueprintmedicines.com","stockEarnings":[{"period":"1week","weight":0.0456},{"period":"1month","weight":0.1416},{"period":"3month","weight":0.3634},{"period":"6month","weight":0.5123},{"period":"1year","weight":1.0815},{"period":"ytd","weight":0.3064}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"蓝图医药公司于2008年10月14日在特拉华州成立，是一家生物制药公司，专注于改善患者的异常活化蛋白激酶基因组驱动的疾病定义的生命。该公司的做法是系统性和可重复鉴定激酶是基因组疾病定义驱动器和手艺的候选药物与治疗窗户，提供显著和持久的临床反应的患者。该公司正致力于几乎所有的努力研发，最初的市场开发，提高资本。该公司是受一些风险相似的其他早期阶段的公司，包括关键个人的依赖;需要开发商业上可行的药物;其他公司，其中有许多是更大和更好的资本竞争;并需要获得足够的额外资金，其药物的开发提供资金。如果公司无法筹集资金需要时或有吸引力的条件，这将被迫推迟，减少，消除或超出许可它的某些研究和开发项目或今后的商业化努力。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.056044},{"month":2,"riseRate":0.666667,"avgChangeRate":0.012381},{"month":3,"riseRate":0.777778,"avgChangeRate":0.045895},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.022821},{"month":5,"riseRate":0.7,"avgChangeRate":0.090385},{"month":6,"riseRate":0.6,"avgChangeRate":0.061595},{"month":7,"riseRate":0.7,"avgChangeRate":0.025465},{"month":8,"riseRate":0.777778,"avgChangeRate":0.074657},{"month":9,"riseRate":0.666667,"avgChangeRate":0.0348},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.024889},{"month":11,"riseRate":0.555556,"avgChangeRate":0.04614},{"month":12,"riseRate":0.555556,"avgChangeRate":0.045056}],"exchange":"NASDAQ","name":"Blueprint Medicines Corporation","nameEN":"Blueprint Medicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blueprint Medicines Corporation,BPMC,Blueprint Medicines Corporation股票,Blueprint Medicines Corporation股票老虎,Blueprint Medicines Corporation股票老虎国际,Blueprint Medicines Corporation行情,Blueprint Medicines Corporation股票行情,Blueprint Medicines Corporation股价,Blueprint Medicines Corporation股市,Blueprint Medicines Corporation股票价格,Blueprint Medicines Corporation股票交易,Blueprint Medicines Corporation股票购买,Blueprint Medicines Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}